Accendra Health (ACH) Common Equity (2009 - 2026)

Accendra Health (ACH) has 18 years of Common Equity data on file, last reported at -$464.8 million in Q1 2026.

• Common Equity for Q1 2026 came in at -$464.8 million, down 181.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$464.8 million (down 181.4% YoY), and the FY2025 annual result was -$461.0 million, down 178.62% from the prior year.
• Common Equity fell to -$464.8 million in Q1 2026 per ACH's latest filing, from -$461.0 million in the prior quarter.
• Over five years, Common Equity peaked at $966.8 million in Q3 2022 and troughed at -$464.8 million in Q1 2026.
• A 5-year average of $571.0 million and a median of $895.7 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2026: Common Equity rose 20.52% in 2022, then sank 181.4% in 2026.
• A 5-year view of Common Equity shows it stood at $966.7 million in 2022, then declined by 2.22% to $945.3 million in 2023, then sank by 37.97% to $586.4 million in 2024, then plunged by 178.62% to -$461.0 million in 2025, then dropped by 0.82% to -$464.8 million in 2026.
• Business Quant data shows ACH's Common Equity at -$464.8 million in Q1 2026, -$461.0 million in Q4 2025, and -$429.5 million in Q3 2025.